PreprintAll rights reservedbioRxiv
KLHL40 gene replacement therapy in severe nemaline myopathy improves survival and skeletal muscle function in a preclinical mouse model
- 1Brigham and Women's Hospital
Related
- The analysis of genetic variants in nine patients with nemaline myopathy: implications for diagnosis and genetic counseling
- AAV vector-mediated ALDH5A1 gene replacement improves survival and metabolic correction in a severe mouse model of SSADH deficiency
- Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach
- Type 1 immunity linked to CMV exposure improves long-term survival in sepsis without shock
- Bacterial toxin sensing induces transient inflammasome-dependent innate immune memory that improves survival during sepsis
BibTeX
@misc{tate2026klhl40,
title = {{KLHL40 gene replacement therapy in severe nemaline myopathy improves survival and skeletal muscle function in a preclinical mouse model}},
author = {G. R. Tate and J. McNulty and J. Widrick and V. A. Gupta},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.23.753846},
url = {https://www.biorxiv.org/content/10.64898/2026.09.23.753846v1},
}
RIS
TY - UNPB
TI - KLHL40 gene replacement therapy in severe nemaline myopathy improves survival and skeletal muscle function in a preclinical mouse model
AU - G. R. Tate
AU - J. McNulty
AU - J. Widrick
AU - V. A. Gupta
PY - 2026
DA - 2026/09/23
PB - bioRxiv
DO - 10.64898/2026.09.23.753846
UR - https://www.biorxiv.org/content/10.64898/2026.09.23.753846v1
ER -